A PHASE 2 OPEN-LABEL, MULTICENTER STUDY TO EVALUATE EFFICACY AND SAFETY OF ZN-c3 IN SUBJECTS WITH HIGH-GRADE SEROUS OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
K-Group Beta, Inc
Start Date
March 21, 2023
End Date
February 29, 2028
Administered By
Duke Cancer Institute
Awarded By
K-Group Beta, Inc
Start Date
March 21, 2023
End Date
February 29, 2028